Showing results (291-300 of 622) with videos related to
Sort By:
Pageof 63
Drug Safety|October 30, 2014
Methodology to assess clinical liver safety dataMichael Merz, Kwan R Lee, Gerd A Kullak-Ublick, et al.Gastroenterology|June 1, 1984
Lipid composition and membrane fluidity in the small intestine of the developing rabbitS M Schwarz, S D Ling, B Hostetler, et al.Journal of Biochemical and Molecular Toxicology|May 15, 1998
Streptozotocin-induced diabetes increases gamma-glutamyltranspeptidase activity but not expression in rat liverJ B Watkins, J E Klaunig, H M Smith, et al.The Journal of Biological Chemistry|May 15, 1986
Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer cultureP B Watkins, S A Wrighton, E G Schuetz, et al.Journal of Pediatric Gastroenterology and Nutrition|January 1, 1986
Effect of gestational age upon prealbumin and retinol binding protein in preterm and term infantsS R Sasanow, A R Spitzer, G R Pereira, et al.Biochimica Et Biophysica Acta|August 21, 1986
Effects of ethinyl estradiol on intestinal membrane structure and function in the rabbitS M Schwarz, J B Watkins, S C Ling, et al.Frontiers in Genetics|April 9, 2025
Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injuryRachel J Church, Benedict Anchang, Brian D Bennett, et al.Clinical Pharmacology and Therapeutics|March 1, 1992
The erythromycin breath test selectively measures P450IIIA in patients with severe liver diseaseK Lown, J Kolars, K Turgeon, et al.The American Journal of Clinical Nutrition|November 1, 1980
13C abundances of nutrients and the effect of variations in 13C isotopic abundances of test meals formulated for 13CO2 breath testsD A Schoeller, P D Klein, J B Watkins, et al.The Journal of Clinical Investigation|November 1, 1992
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytesJ C Kolars, P Schmiedlin-Ren, J D Schuetz, et al.Pageof 63